Is a high-tech enterprise focusing on R&D, manufacture, and sales of in vitro diagnostic (IVD) products.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 10, 2021 | Series C | ¥800M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Guangfa Qianhe Investment Co. | — | Series C |